某些类型的激素疗法比其他疗法更安全吗？来自雌激素与血栓栓塞风险研究的经验教训。 - Suppr

Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.

作者信息

Rexrode Kathryn M, Manson JoAnn E

出版信息

Circulation. 2007 Feb 20;115(7):820-2. doi: 10.1161/CIRCULATIONAHA.106.675405.

DOI:10.1161/CIRCULATIONAHA.106.675405

PMID:17309929

Abstract

摘要

相似文献

Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.

Circulation. 2007 Feb 20;115(7):820-2. doi: 10.1161/CIRCULATIONAHA.106.675405.

Letter by Micheletti and Chevallier regarding article, "Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER Study".

Circulation. 2007 Sep 25;116(13):e362; author reply e363. doi: 10.1161/CIRCULATIONAHA.107.709899.

Hormone therapy and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration and progestogens: the ESTHER study.

Circulation. 2007 Feb 20;115(7):840-5. doi: 10.1161/CIRCULATIONAHA.106.642280.

Hormone therapy and thromboembolic disease.

Curr Opin Hematol. 2007 Sep;14(5):488-93. doi: 10.1097/MOH.0b013e32825f5302.

[Hormone therapy and risk for venous thromboembolism in postmenopausal women].

Rev Prat. 2005 Feb 28;55(4):389-92.

Genetic influence of hormone-replacement therapy on venous thromboembolism.

Lancet. 2003 Oct 11;362(9391):1242. doi: 10.1016/S0140-6736(03)14525-4.

Risk of venous thrombosis with oral versus transdermal estrogen therapy among postmenopausal women.

Curr Opin Hematol. 2010 Sep;17(5):457-63. doi: 10.1097/MOH.0b013e32833c07bc.

[Hormone therapy and risk of venous thromboembolism: new insights from the ESTHER study].

Med Sci (Paris). 2008 Mar;24(3):228-31. doi: 10.1051/medsci/2008243228.

Lower doses of oral estrogen and progestogens as treatment for postmenopausal women.

Semin Reprod Med. 2005 May;23(2):188-95. doi: 10.1055/s-2005-869487.

HRT and venous thromboembolism: more evidence of a link.

CMAJ. 2001 Jan 9;164(1):87.

引用本文的文献

Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up.

Curr Cardiovasc Risk Rep. 2013 Jun 1;7(3):196-202. doi: 10.1007/s12170-013-0305-1.

Loss of estrogen receptor beta decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice.

Age (Dordr). 2010 Mar;32(1):109-21. doi: 10.1007/s11357-009-9119-y. Epub 2009 Nov 12.

Using basic science to design a clinical trial: baseline characteristics of women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS).

J Cardiovasc Transl Res. 2009 Sep;2(3):228-39. doi: 10.1007/s12265-009-9104-y. Epub 2009 May 22.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

BMJ. 2008 May 31;336(7655):1227-31. doi: 10.1136/bmj.39555.441944.BE. Epub 2008 May 20.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Are some types of hormone therapy safer than others? Lessons from the Estrogen and Thromboembolism Risk study.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献